PharmaShots | Incisive News in 3 Shots

Subscribe Now

FDA’s

Eli Lilly and Incyte Receive FDA's EUA for Baricitinib + Remdesivir to Treat Hospitalized Patients with COVID-19

Eli Lilly and Incyte Receive FDA's EUA for Baricitinib + Remdesivir to Treat Hospitalized Patients with COVID-19

November 20, 2020

Inovio Reports FDA's Partial Clinical Hold on P-II/III Trial of INO-4800 Against COVID-19

Inovio Reports FDA's Partial Clinical Hold on P-II/III Trial of INO-4800 Against COVID-19

September 29, 2020

Subtle an AI based Medical Device SubtlePET Receives FDA's 510(K) Clearance

Subtle an AI based Medical Device SubtlePET Receives FDA's 510(K) Clearance

December 6, 2018

Vertex's Kalydeco (ivacaftor) Receives FDA's Expanded Label Approval for Cystic Fibrosis (CF) Aged 12 to < 24 Months

Vertex's Kalydeco (ivacaftor) Receives FDA's Expanded Label Approval for Cystic Fibrosis (CF) Aged 12 to < 24 Months

November 30, 2018

Genentech's ACTpen Receives FDA's Approval for Actemra (tocilizumab) to Treat Rheumatoid Arthritis (RA)- Giant Cell Arteritis (GCA) and Two Forms of Juvenile Arthritis

Genentech's ACTpen Receives FDA's Approval for Actemra (tocilizumab) to Treat Rheumatoid Arthritis (RA)- Giant Cell Arteritis (GCA...

November 27, 2018

Genentech's Venclexta (venetoclax) Receives FDA's Accelerated Approval for Patients with Newly-Diagnosed Acute Myeloid Leukemia (AML)

Genentech's Venclexta (venetoclax) Receives FDA's Accelerated Approval for Patients with Newly-Diagnosed Acute Myeloid Leukemia (A...

November 22, 2018

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us